Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment
Advances in the early diagnosis and treatment have led to increases in breast cancer survivorship. Survivors report cognitive impairment symptoms such as loss of concentration and learning and memory deficits which significantly reduce the patient’s quality of life. Additional therapies are needed t...
Main Authors: | Fabio Ntagwabira, Madison Trujillo, Taylor McElroy, Taurean Brown, Pilar Simmons, Delawerence Sykes, Antiño R. Allen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/4/2008 |
Similar Items
-
Identification of Piperlongumine as Potent Inhibitor of Necroptosis
by: He X, et al.
Published: (2023-05-01) -
Synthesis and Spectroscopic Analysis of Piperine- and Piperlongumine-Inspired Natural Product Scaffolds and Their Molecular Docking with IL-1β and NF-κB Proteins
by: Gabriel Zazeri, et al.
Published: (2020-06-01) -
The Synergistic Effect of Piperlongumine and Sanguinarine on the Non-Small Lung Cancer
by: Marta Hałas-Wiśniewska, et al.
Published: (2020-07-01) -
Piperlongumine Induces Cellular Apoptosis and Autophagy via the ROS/Akt Signaling Pathway in Human Follicular Thyroid Cancer Cells
by: Tsung-Hsing Lin, et al.
Published: (2023-04-01) -
Piperlongumine treatment impacts heart and liver development and causes developmental delay in zebrafish (Danio rerio) embryos
by: Hwang-Ju Jeon, et al.
Published: (2023-06-01)